Sentence examples for switch to open label from inspiring English sources

For the first case, we analyzed those patients whose unsatisfactory response to the blinded drug prompted a switch to open label drug and were started on the more aggressive side of the protocol.

(ii) naso-gastric tube-related lesions (3 vs. 2), (iii) petechial or sub-mucosal bleeding (0 vs. 2), and (iv) duodenal ulcer, (0 vs. 1); the latter was not associated with bleeding but the patient was switched to open label pantoprazole.

Baseline Unsatisfactory initial response – Patients switched to open label drug (MTX, etanercept, and oral corticosteroids).

Unsatisfactory initial response – Patients switched to open label drug (MTX, etanercept, and oral corticosteroids).

Thus, the four stages can be summarized as: Baseline Unsatisfactory initial response – Patients switched to open label drug (MTX, etanercept, and oral corticosteroids).

This was predictable, as the therapeutic course is more complex in those patients who achieved ID status only after switching to open label drug, even if this was the arm of the protocol to which they were initially randomized.

The primary end point was the ASsessment in AS International Working Group criteria for 20% improvement (ASAS20) at Week 12. On or after Week 12, ASAS20 non-responders could switch to open-label adalimumab.

At week 24, patients were switched to open-label adalimumab 40 mg eow.

Efficacy to year 2 is presented for patients randomly assigned to abatacept or infliximab who switched to open-label abatacept.

After week 24 of ADEPT, all patients originally randomly assigned to receive placebo were switched to open-label adalimumab treatment.

Patients randomised to placebo received saline infusions for the first 22 weeks and switched to open-label infliximab at week 24.